ALIGN for Older Adults With Cancer
(ALIGN Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new palliative care approach called ALIGN (Assessing and Listening to Individual Goals and Needs) for older adults with advanced cancer transitioning from a hospital to a skilled nursing facility. Researchers aim to determine the effectiveness of this support and gather valuable feedback from patients and their caregivers. The goal is to assist caregivers in making crucial medical decisions for their loved ones if necessary. This trial may suit individuals who speak English, have advanced cancer, and are being discharged from a hospital in Colorado to a nursing facility. As an unphased trial, it offers a unique opportunity to contribute to innovative care strategies that could enhance quality of life for many.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.
What prior data suggests that the ALIGN intervention is safe for older adults with advanced cancer?
Research has shown that the ALIGN program is designed to improve care for older adults with cancer. ALIGN includes regular online meetings with a palliative care social worker, helping patients and their caregivers plan and make decisions about their care.
Previous studies have not identified any safety concerns with ALIGN. As a support program, not a medication or surgery, it typically involves fewer risks. Overall, ALIGN aims to ensure that the care patients receive aligns with their wishes, providing comfort to both patients and their families.
For those considering joining the trial, knowing that ALIGN has been used safely may offer reassurance.12345Why are researchers excited about this trial?
Researchers are excited about ALIGN because it focuses on improving the transition of older adults with advanced cancer from the hospital to skilled nursing facilities, which is a critical phase often overlooked in standard care. Unlike traditional cancer treatments that primarily target the disease itself, ALIGN emphasizes a holistic approach, offering enhanced resources for caregivers and providing comprehensive support to both patients and their support networks. This method aims to improve quality of life and streamline care processes, potentially leading to better overall outcomes in a demographic that often faces complex care challenges.
What evidence suggests that the ALIGN intervention is effective for older adults with advanced cancer?
This trial will evaluate the ALIGN program, which studies have shown can improve care for patients with advanced cancer by focusing on what matters most to them. Older adults with advanced cancer and their caregivers will participate in this trial. This approach uses palliative care social workers to ensure the care provided aligns with the wishes of patients and their families. Research indicates that ALIGN enhances communication and decision-making, especially when patients cannot express their medical preferences. Early findings suggest that this program could improve the quality of life for older adults with advanced cancer and provide support for their caregivers.36789
Who Is on the Research Team?
Sarguni Singh, MD
Principal Investigator
University of Colorado, Denver
Are You a Good Fit for This Trial?
This trial is for older adults with advanced cancer who are hospitalized and will be discharged to a skilled nursing facility (SNF), as well as their caregivers. Participants must be willing to have virtual visits with a social worker and provide feedback on their condition up to 6 months after enrolling.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the ALIGN palliative care intervention, including virtual visits with a social worker every 1-2 weeks during their skilled nursing facility stay and up to 45 days after discharge.
Follow-up
Participants are monitored for safety and effectiveness after treatment, providing information about their status at 1, 3, and 6 months after enrollment.
Extension/Long-term follow-up
Participants may continue to be monitored for long-term outcomes and caregiver satisfaction.
What Are the Treatments Tested in This Trial?
Interventions
- ALIGN
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
National Institute on Aging (NIA)
Collaborator